Kessler CM - Search Results

1

Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008.

Guh S, Grosse SD, McAlister S, Kessler CM, Soucie JM. Guh S, et al. Among authors: kessler cm. Haemophilia. 2012 Mar;18(2):268-75. doi: 10.1111/j.1365-2516.2011.02692.x. Epub 2011 Dec 12. Haemophilia. 2012. PMID: 22151000 Free PMC article.

2

Cost-effectiveness analysis of alternative factor VIII products in treatment of haemophilia A.

Hay JW, Ernst RL, Kessler CM. Hay JW, et al. Among authors: kessler cm. Haemophilia. 1999 May;5(3):191-202. doi: 10.1046/j.1365-2516.1999.00308.x. Haemophilia. 1999. PMID: 10444287

3

The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A.

Lusher JM, Lee CA, Kessler CM, Bedrosian CL; ReFacto Phase 3 Study Group. Lusher JM, et al. Among authors: kessler cm. Haemophilia. 2003 Jan;9(1):38-49. doi: 10.1046/j.1365-2516.2003.00708.x. Haemophilia. 2003. PMID: 12558777 Clinical Trial.

4

Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.

Parameswaran R, Shapiro AD, Gill JC, Kessler CM; HTRS Registry Investigators. Parameswaran R, et al. Among authors: kessler cm. Haemophilia. 2005 Mar;11(2):100-6. doi: 10.1111/j.1365-2516.2005.01075.x. Haemophilia. 2005. PMID: 15810910

5

Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.

Asatiani E, Kessler CM; Directors of the Comprehensive Hemophilia Treatment Centers in Region III. Asatiani E, et al. Among authors: kessler cm. Haemophilia. 2007 Nov;13(6):685-96. doi: 10.1111/j.1365-2516.2007.01541.x. Haemophilia. 2007. PMID: 17973844 Review.

6

Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease.

Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM, Konkle BA; HTCN Study Investigators. Metjian AD, et al. Haemophilia. 2009 Jul;15(4):918-25. doi: 10.1111/j.1365-2516.2009.02025.x. Epub 2009 Apr 7. Haemophilia. 2009. PMID: 19473418

7

Emerging clinical concerns in the ageing haemophilia patient.

Konkle BA, Kessler C, Aledort L, Andersen J, Fogarty P, Kouides P, Quon D, Ragni M, Zakarija A, Ewenstein B. Konkle BA, et al. Haemophilia. 2009 Nov;15(6):1197-209. doi: 10.1111/j.1365-2516.2009.02066.x. Epub 2009 Jul 21. Haemophilia. 2009. PMID: 19686466 Review.

8

Haemophilia 2011.

Lee C, Kessler C, Makris M, Gough S. Lee C, et al. Haemophilia. 2011 Jan;17(1):1. doi: 10.1111/j.1365-2516.2010.02478.x. Haemophilia. 2011. PMID: 21199186 No abstract available.

9

Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008).

Neufeld EJ, Kessler CM, Gill JC, Wilke CT, Cooper DL; Htrs Investigators. Neufeld EJ, et al. Among authors: kessler cm. Haemophilia. 2011 Jul;17(4):650-6. doi: 10.1111/j.1365-2516.2010.02483.x. Epub 2011 Feb 7. Haemophilia. 2011. PMID: 21299750

10

Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres.

Ragni MV, Fogarty PJ, Josephson NC, Neff AT, Raffini LJ, Kessler CM. Ragni MV, et al. Among authors: kessler cm. Haemophilia. 2012 Jan;18(1):63-8. doi: 10.1111/j.1365-2516.2011.02554.x. Epub 2011 May 4. Haemophilia. 2012. PMID: 21539695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page